Article

HER2-targeting CAR-T cells show highly efficient anti-tumor activity against glioblastoma both in vitro and in vivo

2024-02-13

Abstract excerpt

<title>Abstract</title> <p>Glioblastoma (GBM) is the most common and aggressive malignant brain tumor in adults. Current treatment options for GBM include surgical resection, radiation, and chemotherapy, which predominantly only slow cancer growth and reduce symptoms, resulting in a 5-year survival rate of no more than 10%. Chimeric antigen receptor (CAR)-T cell therapy is a new class of cellular immunotherapies...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: e1dbda9d-3746-5800-8fba-a0d3dcc9e87a
DOI: 10.21203/rs.3.rs-3926646/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

HER2-targeting CAR-T cells show highly efficient anti-tumor activity against glioblastoma both in vitro and in vivoDOI 10.21203/rs.3.rs-3926646/v1Read

HER2-targeting CAR-T cells show highly efficient anti-tumor activity against glioblastoma both in vitro and in vivoSemantic proximity Read

GD2-targeting CAR-T cells enhanced by transgenic IL-15 expression are an effective and clinically feasible therapy for glioblastomaSemantic proximity Read

Gene Targets of CAR-T Cell Therapy for GlioblastomaSemantic proximity Read

Autologous Anti-GD2 CAR T Cells Efficiently Target Primary Human GlioblastomaSemantic proximity Read

CAR T cell therapy for glioblastoma: A review of the first decade of clinical trialsSemantic proximity Read

A Bi-Specific T Cell-Engaging Antibody Triggers Protective Immune Memory and Glioma Microenvironment Remodeling in Immune Competent Preclinical ModelsSemantic proximity Read

Armored Bicistronic CAR T Cells with Dominant-negative TGF-β Receptor II to Overcome Resistance in GlioblastomaSemantic proximity Read

Allogeneic CAR T Cells: An Alternative to Overcome Challenges of CAR T Cell Therapy in GlioblastomaSemantic proximity Read

Adoptive transfer of IL13Rα2-specific T cells for the treatment of glioblastoma: building on clinical achievements with second-generation CARsSemantic proximity Read

Multivalent in vivo delivery of DNA-encoded bispecific T cell engagers effectively controls heterogeneous GBM tumors and mitigates immune escapeSemantic proximity Read

Highly potent novel multi-armoured IL13Ra2 CAR-T subverts the immunosuppressive microenvironment of GlioblastomaSemantic proximity Read

Transport vehicle–mediated TREM2 PET maps myeloid cells in the glioblastoma microenvironmentSemantic proximity Read